M32.11 identifies endocarditis occurring as a direct manifestation of systemic lupus erythematosus (SLE), also called Libman-Sacks disease — the nonbacterial verrucous endocarditis characteristic of SLE.
Verified May 8, 2026 · 4 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 0
- Region
- General
Documentation tips
What should appear in the chart to support M32.11.
Source · Editorial brief grounded in 4 cited references ↓
- Document the explicit causal link: 'endocarditis due to systemic lupus erythematosus' or 'Libman-Sacks disease in the setting of SLE' — without this, a coder cannot distinguish M32.11 from infectious endocarditis.
- Record the valve(s) affected and any echocardiographic findings (e.g., mitral valve verrucous lesions, valve regurgitation) to support medical necessity and distinguish from infectious or rheumatic etiologies.
- If additional SLE organ involvement is present (renal, pulmonary, etc.), document each manifestation separately so all applicable M32.1x codes can be assigned — a single encounter may carry multiple M32.1 subcodes.
- Note whether SLE is drug-induced (M32.0) or idiopathic; the cardiac manifestation code does not differentiate, but the root etiology affects overall coding and may affect payer adjudication.
- Confirm active versus historical disease status: M32.11 requires active, current endocarditis attributable to SLE. Resolved or historical SLE cardiac involvement codes differently (Z86.29 for history).
Common coding pitfalls
The recurring mistakes coders make with M32.11 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Assigning M32.11 when endocarditis has an infectious etiology in a known SLE patient — infectious endocarditis (I33.0, I33.9) is coded first in that scenario; M32.11 is strictly for the nonbacterial Libman-Sacks form.
- Defaulting to M32.10 (organ involvement unspecified) or M32.9 (SLE unspecified) when the chart clearly documents endocarditis — always code to the highest documented specificity.
- Confusing M32.11 with M32.12 (pericarditis in SLE) — pericarditis and endocarditis are distinct cardiac manifestations with separate codes; confirm which structure is involved.
- Omitting M32.11 when SLE is already coded elsewhere in the encounter — each documented organ manifestation under M32.1 deserves its own code; co-coding multiple M32.1x subcodes in the same encounter is correct and expected.
- Using M32.11 for discoid lupus erythematosus (L93.0) with cardiac findings — the Excludes1 note at the M32 category level prohibits using any M32 code for discoid lupus.
Clinical context
Source · Editorial summary grounded in 4 cited references ↓
Use M32.11 when documentation explicitly links endocarditis to SLE as its underlying cause. This code captures Libman-Sacks disease, the sterile, immune-complex-mediated valvular lesion most commonly affecting the mitral valve in SLE patients. It sits under parent code M32.1, which groups all SLE presentations with confirmed organ or system involvement — the physician must document both the SLE diagnosis and the cardiac manifestation for this code to be defensible.
M32.11 is distinct from infectious endocarditis (coded in the I33 range) and from pericarditis in SLE (M32.12). Do not conflate them. If the endocarditis has a documented bacterial, fungal, or other infectious etiology in a known SLE patient, code the infectious endocarditis first and add M32.9 (or a more specific M32 code) as a comorbidity. Reserve M32.11 strictly for the lupus-driven, noninfectious form.
When SLE is the underlying disease driving multiple organ manifestations simultaneously — for example, both endocarditis and glomerular disease — code each applicable M32.1x code. M32.11 alone does not capture renal involvement; pair it with M32.14 or M32.15 as appropriate. Never default to M32.10 (organ involvement unspecified) or M32.9 (unspecified SLE) when the specific organ manifestation is documented.
Inclusion & exclusion notes
Per the official ICD-10-CM Tabular List.
Source · CDC ICD-10-CM Official Tabular List · 2026
Includes
- Libman-Sacks disease
Sibling codes
Other billable codes under M32.1 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 4 cited references ↓
01What is Libman-Sacks disease and why does it map to M32.11?
02Can M32.11 and an infectious endocarditis code appear on the same claim?
03Should M32.11 be the principal diagnosis or a secondary code?
04What if the patient has both M32.11 (endocarditis) and M32.14 (glomerular disease) in SLE?
05Is M32.11 valid for drug-induced SLE with endocarditis?
06How does M32.11 differ from M32.12?
07What documentation is needed to avoid a downcode to M32.9 or M32.10?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (FY2026, effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M30-M36/M32-/M32.11
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M32.11
- 04outsourcestrategies.comhttps://www.outsourcestrategies.com/blog/how-report-systemic-lupus-erythematosus-with-correct-icd-10-codes/
Mira AI Scribe
Mira's AI scribe captures the treating clinician's explicit statement linking endocarditis to systemic lupus erythematosus, echocardiographic findings (valve affected, lesion morphology consistent with Libman-Sacks), current SLE disease activity, and any concurrent organ involvement documented in the same encounter. This prevents the record from defaulting to unspecified SLE (M32.9) or infectious endocarditis codes, both of which misrepresent the clinical picture and create audit exposure.
See how Mira captures M32.11 documentation